JUN and cervical cancer: Although inhibiting NFkB signaling showed a trend towards reducing HeLa cancer cell migration the results were not significantly different from the control while inhibiting KPNB1 using INI-43 and inhibiting AP-1 signaling using SP600125 significantly reduced the migratory ability of cervical cancer cells (Figure 9A).